Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine vs Clonidine for Opioid Withdrawal in ED
NCT03174067Phase 4Completed
- Sponsor
- St. Joseph's Health Centre
- Start
- Mar 2013
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of buprenorphine in opioid withdrawal, opioid use disorder (OUD), sponsored by St. Joseph's Health Centre. Started Mar 2013; status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid withdrawalopioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03174067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03174067.